Cite

    Congdon, E., Lin, Y., Rajamohamedsait, H., Shamir, D., Krishnaswamy, S., Rajamohamedsait, W., Rasool, S., Gonzalez, V., Levenga, J., Gu, J., Hoeffer, C., & Sigurdsson, E. (2016). affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy. Molecular neurodegeneration, 11(1), 1–24. http://access.bl.uk/ark:/81055/vdc_100080681666.0x0000c3